Wei (William) Cao

All filings by Wei (William) Cao on record concern Cellular Biomedicine Group, Inc. In total, 17 filings cover trades dated from 22 May 2014 to 2 March 2016.

Both buying and selling appear: 1 purchase worth €366k, against 9 sales worth €1.7M. Taken together, the sales exceed the purchases by €1.4M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 5 option exercises. 2016 to date brings no purchases and 3 sales.

The record was last updated on 14 April 2016 with an option exercise (€50k) in Cellular Biomedicine Group, Inc. The most recent open-market purchase was published on 30 May 2014, 4,546 days ago. Typically, a trade is published a median of 6 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.